As reported earlier, serum sclerostin levels did not differ in men vs. women, patients with hypertension vs. normotensive, diabetic vs. non-diabetic, and those that did or did not suffer from metabolic syndrome (data not shown). Here, SOST is linked to metabolic syndrome.